Zaroxolyn Side Effects
Generic name: metolazone
Note: This document contains side effect information about metolazone. Some of the dosage forms listed on this page may not apply to the brand name Zaroxolyn.
Some side effects of Zaroxolyn may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to metolazone: oral tablet
Along with its needed effects, metolazone (the active ingredient contained in Zaroxolyn) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking metolazone:Incidence not known
- Black, tarry stools
- bleeding gums
- blistering, peeling, or loosening of skin
- blood in urine or stools
- blurred vision
- bone pain
- chest pain
- clay-colored stools
- cold sweats
- dark urine
- decreased urine
- dizziness, faintness, or lightheadedness when getting up from lying or sitting position
- dry mouth
- fast, irregular, pounding, or racing heartbeat or pulse
- flushed, dry skin
- fruit-like breath odor
- general tiredness and weakness
- incoherent speech
- increased hunger
- increased thirst
- increased urination
- joint or muscle pain
- light-colored stools
- loss of appetite
- lower back or side pain
- metallic taste
- mood changes
- muscle pain or cramps
- nausea and vomiting
- numbness or tingling in hands, feet, or lips
- pain in lower legs
- painful or difficult urination
- pinpoint red spots on skin
- red irritated eyes
- red skin lesions, often with a purple center
- redness or swelling of lower leg
- shortness of breath
- sore throat
- sores, ulcers, or white spots in mouth or on lips
- sugar in the urine
- swelling of face, ankles, or hands
- swollen or painful glands
- tightness in chest
- troubled breathing
- unexplained weight loss
- unpleasant breath odor
- unusual bleeding or bruising
- unusual tiredness or weakness
- upper right abdominal pain
- vomiting of blood
- weak pulse
- yellow eyes and skin
Get emergency help immediately if any of the following symptoms of overdose occur while taking metolazone:Symptoms of overdose
- irregular, fast or slow, or shallow breathing
- pale or blue lips, fingernails, or skin
- unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness
- weakness and heaviness of legs
Some side effects of metolazone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:Incidence not known
- Blue-green to black skin discoloration
- burning, tingling, numbness, or pain in the hands, arms, feet, or legs
- cracked, dry, or scaly skin
- decreased interest in sexual intercourse
- feeling of constant movement of self or surroundings
- hives or welts
- inability to have or keep an erection
- loss in sexual ability, desire, drive, or performance
- pain, redness, or sloughing of skin at place of injection
- sensation of pins and needles
- sensation of spinning
- stabbing pain
For Healthcare Professionals
Applies to metolazone: oral tablet
A rare case of hyperosmolar nonketotic hyperglycemia is associated with metolazone (the active ingredient contained in Zaroxolyn)
Metabolic side effects are the most common and profound. The rapid onset of hyponatremia or hypokalemia is often sudden and may be profound, particularly if metolazone is given with a loop diuretic. Hypokalemia may be important in patients with underlying cardiac arrhythmias. Metolazone may increase serum calcium and uric acid levels and lower serum magnesium and phosphate levels. Glucose intolerance is reported in rare cases.
Cardiovascular side effects are uncommon. Postural hypotension is reported in less than 5% of patients. Rare cases of venous thrombosis are reported, thought to be due to metolazone-induced hypovolemia and increased serum concentrations of clotting factors. Rare cardiovascular side effects also include palpitations, hypovolemia, and chest pain.
Renal insufficiency, manifest as a rise in serum creatinine and BUN, may occur, although, in most cases, creatinine clearance increases as a result of metolazone (the active ingredient contained in Zaroxolyn) therapy.
Nervous system side effects include headache, dizziness, and fatigue. Two cases of syncope and seizures are reported. Metolazone-induced hypovolemia and electrolyte changes may induce hepatic encephalopathy in some patients.
It is not clear whether the patients who developed syncope and seizure activity were hypotensive or hypovolemic at the time of the seizures or that metolazone can definitively be implicated. In one case the patient was also taking theophylline and had hypomagnesemia, which may be a complication of metolazone therapy.
Hypersensitivity reactions include rare case reports of necrotizing vasculitis, angiitis, and pruritic rashes.
A case of cutaneous hypersensitivity angiitis has been reported in a patient who had previously tolerated thiazide diuretics, indicating that, despite the chemical similarity between thiazides and metolazone, there is not necessarily cross-reactivity.
Hematologic abnormalities are rare. Cases of reversible hypoplastic anemia, aplastic anemia, agranulocytosis, and mild leukopenia are reported.
Gastrointestinal side effects are rare, and include a case of acute pancreatitis. Nausea, vomiting, anorexia, and abdominal bloating are also rare.
Hepatic side effects include a rare case of cholestatic jaundice.
Musculoskeletal cramps are associated with metolazone (the active ingredient contained in Zaroxolyn) therapy, as with other diuretics, and may be associated with electrolyte disorders and rapid intravascular volume shifts.
More Zaroxolyn resources
- Zaroxolyn Prescribing Information (FDA)
- Zaroxolyn MedFacts Consumer Leaflet (Wolters Kluwer)
- Zaroxolyn Concise Consumer Information (Cerner Multum)
- Zaroxolyn Advanced Consumer (Micromedex) - Includes Dosage Information
- Zaroxolyn Monograph (AHFS DI)
- Metolazone Prescribing Information (FDA)
- Metolazone Professional Patient Advice (Wolters Kluwer)
- Mykrox Prescribing Information (FDA)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.